SUDEEPPHRM logo

Sudeep Pharma Limited

SUDEEPPHRM·NSE·
₹1,020.00▲ +11.90 (+1.18%)
Market Cap11301.07 Cr
PE Ratio65.81
Volume36,528
Day High - Low1030.00 - 1000.00
52W High-Low1378.00 - 524.05

Sudeep Pharma Limited (SUDEEPPHRM): company summary

The company's business is improving, with annual revenue rising 27.9% and annual net profit growing 25.4%.

Sudeep Pharma Limited (SUDEEPPHRM) is a small-cap Chemicals company valued at ₹11,301 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move
Sudeep Pharma Limited last traded at ₹1,020, modestly up 1.18% on the day.
Recent developments
2026-09-04: Sudeep Pharma's stock hit a 52-week high, with the company among eight commodities stocks that surged to fresh highs in the past month, with gains ranging from 14% to 53%.
Financial performance
The company's business is improving, with annual revenue rising 27.9% and annual net profit growing 25.4%. The latest quarter saw revenue and net profit both rise compared to the same quarter a year earlier, with revenue up 26.6% and net profit up 30.9%. However, the net profit margin narrowed slightly to 27.1% from 27.7% in the prior year.
Valuation multiples
The stock trades at 65.8 times earnings, 15.50 times book value. It yields 0.1%.
Things to watch
The stock is 12.9% below its 52-week high. Domestic institutional holding fell by 2.46 percentage points in the quarter. The net profit margin narrowed by 0.6 percentage points, and the return on equity is 19.6%, which is lower than the return on capital employed of 22.8%.
Where it stands
Sudeep Pharma Limited's latest quarter revenue and net profit both rose compared to the same quarter a year earlier, with net profit growing faster. The stock is 12.9% below its 52-week high, and the net profit margin narrowed slightly. The company's return on capital employed is higher than its return on equity.

Summarised by DocStoX's model on 2026-10-03 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.

DocStoX Score
6.2/10
Fair
Fair Value
Sign in to see
ROE
19.57%
Strong
P/E
65.81x
Expensive
Debt / Equity
0.17
Low
Industry
Chemicals
Pharmaceuticals
Overall View
Mixed

Price performance

Day₹1000
₹1030
52W₹524.05
₹1378
DocStoX take

Supported by growth (8.5) and risk (8.5), but held back by valuation (0.0). Growth looks strong at 8.5, but that is offset by valuation at 0.0. We are calling it Mixed rather than resolving the conflict for you.

DocStoX score

Low confidence
6.2
/10
Fair
Quality
Excellent
ROE 19.6%
Valuation
Expensive
P/E 65.8×
Growth
Strong
Revenue +24.5% 5Y CAGR
Risk
Low risk
D/E 0.17
Momentum
Firm
58% of 52-week range

At a glance

Market Cap
₹11,301 Cr
52W High / Low
₹1378 / ₹524
Dividend Yield
0.12%
Promoter Holding
76.15%
EPS (TTM)
₹15.50
Book Value
₹78.21

Key highlights

  • Profit compounding 39% a year
  • Low leverage — D/E 0.17
  • Profitable in all of the last 5 years
  • Valuation is weak (0.0/10)
  • Expensive at 66× earnings
4 Positives2 Watchouts

Growth

Financials

Shareholding

Technicals

Peers

News

Forecasts

About the company

More data

Filings, corporate actions and ownership detail — opened on demand.

More Chemicals stocks · Pharmaceuticals

Sudeep Pharma Limited peers in Chemicals

Other Chemicals stocks on the NSE & BSE. See the full Chemicals sector list.